Why is Kobo Biotech falling/rising?

As of 09-Sep, Kobo Biotech Ltd's stock price is currently at Rs 2.28, showing no change (0.00%). The stock has been underperforming, with a 1-week decline of 3.80% and a 1-month decline of 7.32%. It is trading below all moving averages, indicating a bearish trend. Additionally, the company has not declared results in the last six months, which raises concerns about its long-term fundamental strength. The negative financial indicators include a significant drop in net sales and operating profit over the past five years, alongside a high debt-to-equity ratio. Despite a recent increase in investor participation, the overall sentiment remains weak due to the company's poor performance and lack of transparency.
In the broader market context, Kobo Biotech's performance contrasts sharply with the Sensex, which has seen a positive return of 1.18% over the past week and 1.56% over the past month. The stock's consistent underperformance against the benchmark over the last three years, combined with a 1-year return of -23.23%, highlights its struggle to attract investor confidence. This underperformance, coupled with the company's flat results and risky trading conditions, suggests that the stock is not only falling in value but also facing significant challenges in regaining stability in the market.